DARCY BEVILL: Open Payments
NPI 1831491265 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 24 payments from 12 companies in 2025. Trend: 2023 $859 · 2024 $400 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $183 |
| Lilly USA, LLC | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Amgen Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: Rybelsus, MOUNJARO, JARDIANCE, Cologuard Collection Kit, Wegovy, Ozempic, AIRSUPRA, VRAYLAR.
Industry payments across TX — which companies pay providers there.
